A Novel and Selective Nociceptin Receptor (<scp>NOP</scp>) Agonist (1‐(1‐((cis)‐4‐isopropylcyclohexyl)piperidin‐4‐yl)‐1H‐indol‐2‐yl)methanol (<scp>AT</scp>‐312) Decreases Acquisition of Ethanol‐Induced Conditioned Place Preference in Mice
Nurulain T. Zaveri(Astraea Therapeutics (United States)), Kabirullah Lutfy(University of California, Los Angeles), Abdul Hamid(Charles R. Drew University of Medicine and Science), Paul Marquez(Western University of Health Sciences), Michael E. Meyer(Astraea Therapeutics (United States)), Willma E. Polgar(SRI International)
Cited by 21
Related Papers
Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity
|Nature|2014|927
Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems
|Pharmacological Reviews|2016|290
Buprenorphine-Induced Antinociception Is Mediated by μ-Opioid Receptors and Compromised by Concomitant Activation of Opioid Receptor-Like Receptors
|Journal of Neuroscience|2003|214
Activities of mixed NOP and μ‐opioid receptor ligands
|British Journal of Pharmacology|2007|62